AstraZeneca wins appeal on Prilosec patents
25 August 2008
Eklavya Gupte, London
The US Court of Appeals for the Federal Circuit has upheld the ruling of a District Court in favour of AstraZeneca in a patent infringement case against Apotex Corp and Impax Laboratories over its heartburn drug Prilosec
On August 20, the three-judge panel affirmed the May 2007 decision of US District Court Judge Barbara S Jones and ruled that Apotex and Impax had infringed two of AstraZeneca's patents (4,786,505 and 4,853,230).
AstraZeneca has said that it will take Apotex and Impax back to the District Court to seek damages for the infringing sales.
“AstraZeneca will seek a ruling that Apotex's and Impax’s infringing...
Only subscribers have complete access to Managing IP Magazine,
log in or
subscribe now.
Alternatively take a
free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial